In addition, other autoantibodies showed some potential detection value for CRC, including autoantibodies against IMPDH2, MDM2, HSP60, RPL13, VIL1, CENPF, RGN, and PRDX3. Here, IMPDH2 is linked to colorectal carcinoma.